Latest Articles

  • Podcast Power

    January 20, 2022

    Can therapeutic podcasts be beneficial? By Dr Tom MacLaren, Consultant Psychiatrist at Re:Cognition Health   As we have all learned to adapt to new ways of working, […]

  • Blue Monday

    January 17, 2022

    Brighten up your Blue Monday! Dr Tom MacLaren, Consultant Psychiatrist at Re:Cognition Health shares his top tips to help you overcome the Monday blues today:   Blue Monday is […]

  • Long Covid Anxiety

    January 6, 2022

    Struggling with Long Covid anxiety? Dr Tom MacLaren, Consultant Psychiatrist at Re:Cognition Health was featured in the Metro in an article exploring anxiety associated with Long Covid. […]

  • “We invest in people” Accreditation

    December 22, 2021

      Re:Cognition Health Awarded “We invest in people” Accreditation   We are delighted to announce that Re:Cognition Health has been accredited with “We invest in people”, a […]

  • Dr Emer MacSweeney on Good Morning Washington

    December 21, 2021

    Dr Emer MacSweeney on Good Morning Washington   Dr Emer MacSweeney speaks with Good Morning Washington about clinical trials for Alzheimer’s which are currently taking place in the USA […]

  • Neurofeedback headbands

    October 18, 2021

    Dr Allder shares his insight with the BBC     Consultant Neurologist Dr Steve Allder was featured in an article on BBC.co.uk about the use of smart […]

  • Alzheimer’s and Anxiety

    September 27, 2021

    Alzheimer’s and Anxiety Dr MacSweeney explains the importance of anxiety coupled with short term memory loss   Scientists have demonstrated  that changes in our brain start approximately […]

  • Alzheimer’s Disease in Down Syndrome

    September 13, 2021

    By Martyn Blairs Alzheimer Disease (AD) neuropathology in Down Syndrome (DS) stems from triplication of the amyloid precursor protein (APP) gene on chromosome 21. The APP gene […]

  • Cognitive Deficits in people who have recovered from COVID-19

    September 13, 2021

      By Martyn Blairs Cognitive deficits are defined by impairment of learning and memory processes. There are growing concerns about the possible cognitive consequences of COVID-19. There […]

  • New Medical Cannabis Service Launched

    September 13, 2021

      ​​Re:Cognition Health is delighted to launch the national Medical Cannabis Service designed to help alleviate pain and other symptoms related to physical, psychological and neurological conditions. […]

1 2 5 6 7 8 9 22 23

Help us make a difference in cognitive health

Sign Up Now